Nonalcoholic Fatty Liver Clinical Trials

38 clinical trials for Nonalcoholic Fatty Liver across international registries, including 3 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Harnessing Macrophage Lysosomal Lipid Metabolism in Obesity — RECRUITING · NA
• Gepaktiv vs UDCA and Ademetionine in MAFLD With Hepatomegaly — RECRUITING · NA
• Longitudinal Multi-Omic Profiles to Reveal Mechanisms of Obesity-Mediated Insulin Resistance — RECRUITING · NA
• Digital Therapy for Fatty Liver Disease — ACTIVE_NOT_RECRUITING · NA
• Effect of Anti-osteoporotic Medications on Nonalcoholic Fatty Liver Disease — COMPLETED · PHASE4
• Effect of a GnRH Analog on Hepatic Steatosis — ACTIVE_NOT_RECRUITING · PHASE4
• Iron Reduction for the Treatment of Diabetes and Nonalcoholic Fatty Liver Disease — COMPLETED · NA
• Prevalence of NAFLD and Advanced Fibrosis in Patients With Type 1 Diabetes — ACTIVE_NOT_RECRUITING
• A Longitudinal Observational Study of Patients With Nonalcoholic Steatohepatitis (NASH) and Related Conditions Across the Entire Spectrum of Nonalcoholic Fatty Liver Disease (NAFLD) — COMPLETED
• Weight, Energy, Lipids, and the Liver (WELL) Study — ACTIVE_NOT_RECRUITING · NA
• The Impact of Ibutamoren on Nonalcoholic Fatty Liver Disease — COMPLETED · PHASE2
• Accurate Point of Care Liver Disease Diagnostics — ACTIVE_NOT_RECRUITING
• Effect of Adding TENS to Mediterranean Diet on Appetite and Liver Enzymes in Nonalcoholic Fatty Liver Patients — NOT_YET_RECRUITING · NA
• Safety Study of OA-235i in Subjects With Nonalcoholic Steatohepatitis — COMPLETED · PHASE1
• Conditionally Increased Output (CIO) Enhanced Ultrasound System — COMPLETED · NA
• A Phase 3 Study Evaluating the Safety and Efficacy of Denifanstat in Patients With MASLD and MASH — WITHDRAWN · PHASE3
• A Phase 3 Study Evaluating the Safety and Efficacy of Denifanstat in Patients With MASH and F2/F3 Fibrosis — WITHDRAWN · PHASE3
• The Liver Health Study for Patients with NAFLD — COMPLETED · NA
• Comparative and Additive Diagnostic Performance of Magnetic Resonance Elastography (MRE) and Corrected-T1 (cT1) for Fibrosis and Inflammation in Nonalcoholic Steatohepatitis (NASH) Using Histology As Reference — COMPLETED
• Aspirin for the Treatment of Nonalcoholic Fatty Liver Disease — COMPLETED · PHASE1
• Metabolic Pathology of Pediatric NAFLD — OTHER · NA
• Nonalcoholic Fatty Liver Disease - Intermittent Calorie Restriction (FLICR) Study — COMPLETED · NA
• Noninvasive Biomarkers of Metabolic Liver Disease 1.1 — COMPLETED · NA
• Cardio-Metabolic Risk Evaluation in Overweight and Obese Children — OTHER
• Molecules Associated With the Presence and Severity of Nonalcoholic Fatty Liver Disease — COMPLETED
• Non-invasive Biomarkers of Metabolic Liver Disease (NIMBLE) Study 1.2 — COMPLETED
• Efficacy and Safety of Guanabenz for Nonalcoholic Fatty Liver Disease — OTHER · PHASE2
• Study on GS300 on NAFLD — OTHER · NA
• Efficacy and Safety of Elobixibat in Combination With Cholestyramine for Nonalcoholic Fatty Liver Disease — COMPLETED · PHASE2
• A Study of the Efficacy and Safety of PXL770 Versus Placebo After 12 Weeks of Treatment in Patients With NAFLD — COMPLETED · PHASE2
• A Study to Assess the Pharmacokinetics of PXL770 After 4 Weeks of Treatment in Subjects With NAFLD — COMPLETED · PHASE1
• Curcumin Supplement in Nonalcoholic Fatty Liver Patients — COMPLETED · PHASE2
• Feasibility of VIIT in Adults With NASH — COMPLETED · NA
• Non-invasive Evaluation of Liver Fibrosis, Steatosis, and NASH in NAFLD — OTHER · NA
• Fatty Liver Study in Patients With Type II Diabetes — TERMINATED · PHASE4
• Great China Fatter Liver Consortium (GC_FLC) Study to Assess the Progress of NAFLD/NASH in Chinese — NOT_YET_RECRUITING
• Vitamin D Replacement in Nonalcoholic Fatty Liver Disease — COMPLETED
• Crassostrea Gigas for Liver Health — OTHER · NA

Refine this search